Gender	Male
E-mail	juan.wisnivesky@mssm.edu
	juan.wisnivesky@mountsinai.org
Education and Training	MPH, Columbia University
Awards	1998 Young Investigator Award CHEST
	1996 Outstanding House Officer Award Montefiore Medical Center, Albert Einstein College of Medicine
	1990 Cum Laude University of Buenos Aires School of Medicine

Dr. Wisnivesky is a pulmonologist and clinical epidemiologist whose research focuses on asthma, cancer epidemiology and outcomes research. He is the Principal Investigator (PI) of two R01s to conduct secondary data analyses using the Surveillance, Epidemiology and End Results (SEER)-Medicare registry to evaluate the diagnosis, staging, and treatment of lung cancer. He is also the PI of an American Cancer Society funded cohort study assessing the determinants of disparities in the diagnosis and treatment of lung cancer. Dr. Wisnivesky has considerable experience using the SEER registry and more recently the SEER-Medicare database. He has published several manuscripts using these databases addressing issues related to the diagnosis, treatment, disparities in care, and outcomes of patients with lung and esophageal cancer.
 
He is also the PI of an NIH-funded Phase I/II randomized controlled trial evaluating the efficacy of a novel herbal medicine for the treatment of asthma. He received a K award from the Agency for Healthcare Research and Quality (AHRQ) to identify determinants of medication adherence and outcomes among inner-city asthmatics and a grant funded by the New York State Department of Health to assess the management of minority asthmatics. He has also been involved in several inpatient, outpatient and physician studies assessing the treatment and outcomes of inner-city asthmatics. He was the PI of an R03 grant to validate a pulmonary tuberculosis prediction rule.
News
Mount Sinai Study Shows that Language Barriers may Interfere with the Care of Asthma Patients.
Find out more here

Education and Training	MPH, Columbia University

Research interests include:
Asthma, lung cancer screening, Tuberculosis

Wisnivesky J, Kattan M, Evans D, Leventhal H, Musumeci T, McGinn T, Halm E. Assessing the Relationship between Language Proficiency and Asthma Morbidity amongst Inner-city Asthmatics. Medical Care;-in press.

Kates MR, Perez X, Gribetz J, Swanson SJ, McGinn T, Wisnivesky JP. Validation of a Model to Predict Perioperative Mortality from Lung Cancer Resection in the Elderly [Epub ahead of print]. J Respir Crit Care Med 2008 Nov 21;.

Wisnivesky J, Sampson H, Berns S, Kattan M, Halm E. Lack of association between indoor allergen sensitization and asthma morbidity in inner-city adults. J Allergy Clin Imnunol 2007; 120(1): 113-120.

Wisnivesky J, Halm EA. Sex differences in lung cancer survival: do tumors behave differently in elderly women?. J Clin Oncol 2007; 25(13): 1705-1712.

Wisnivesky J, Henschke C, Yankelevitz D. Diagnostic percutaneous transthoracic needle biopsy does not affect survival of stage I lung cancer. Am J Respir Crit Care Med 2006; 174(6): 684-688.

Wisnivesky J, McGinn T, Henschke C, Hebert P, Iannuzzi M, Halm E. Ethnic disparities in the treatment of stage I non-small cell lung cancer. Am J Respir Crit Care Med 2005; 171: 1158-1163.

Wisnivesky J, Yankelevitz D, Henschke C. The effect of tumor size on curability of Stage I non-small cell lung cancers. Chest 2004; 126: 761-765.

Wisnivesky J, Kaplan J, McGinn T, Henscke C, Crystal RG. Evaluation of clinical parameters to predict positive culture for Mycobacterium Tuberculosis in inpatients. Arch Int Med 2000; 160: 2471-2476.